Sealing the Leak: A Prospective Study on Risk Factors and Outcomes of Expectant Management in Preterm Premature Rupture of Membranes
Keywords:
PPROM, Preterm labor, Neonatal outcome, Expectant management, ChorioamnionitisAbstract
Background: Preterm premature rupture of membranes (PPROM) is a significant contributor to perinatal morbidity and mortality. This study evaluates risk factors, clinical presentation, and outcomes of expectant management in antenatal women with PPROM between 28 and 37 weeks of gestation.
Methods: A prospective observational study was conducted at Saveetha Medical College from January 2023 to March 2024. Twenty-one antenatal women with singleton pregnancies complicated by PPROM were enrolled. Clinical, microbiological, and neonatal outcomes were assessed. Data were analyzed using SPSS v21, with p-values ≤0.05 considered statistically significant.
Results: Most patients presented within 11 hours of membrane rupture. The most common organisms identified were E. coli, Klebsiella pneumoniae, and Pseudomonas aeruginosa. Conservative management led to favorable outcomes in early PPROM. Neonatal morbidities included jaundice and birth asphyxia (12% each), and one stillbirth was recorded. Chorioamnionitis and urinary tract infections were key maternal complications.
Conclusion: Expectant management in stable early PPROM cases, supported by antibiotics and corticosteroids, can lead to improved neonatal outcomes. However, strict monitoring is vital to detect complications such as chorioamnionitis
Downloads
References
Simhan HN, Canavan TP. Preterm premature rupture of membranes: diagnosis, evaluation and management strategies. BJOG. 2005 Mar;112 Suppl 1:32-7. [PMID: 15715585]
Bhagat M, Kumar R, Kaur H. Maternal and neonatal outcome in preterm premature rupture of membranes. Int J Reprod Contracept Obstet Gynecol. 2016;5(3):708–712. [PubMed Indexed]
Kenyon S, Boulvain M, Neilson JP. Antibiotics for preterm rupture of membranes. Cochrane Database Syst Rev. 2013 Dec;12(12):CD001058. [PMID: 24318412]
Mercer BM. Preterm premature rupture of the membranes. Obstet Gynecol. 2003 Jan;101(1):178–193. [PMID: 12517661]
Parry S, Strauss JF. Premature rupture of the fetal membranes. N Engl J Med. 1998 Feb;338(10):663-670. [PMID: 9486990]
ACOG Committee Opinion No. 455: Magnesium sulfate before anticipated preterm birth for neuroprotection. Obstet Gynecol. 2010 Jun; 115(6):1328-1333. [PMID: 20502301]
Roberts D, Dalziel S. Antenatal corticosteroids for accelerating fetal lung maturation for women at risk of preterm birth. Cochrane Database Syst Rev. 2006 Jul; 3:CD004454. [PMID: 16856047]
Singh N, Pattnaik L, Panda SR, et al. Fetomaternal Outcomes in Women Affected With Preterm Premature Rupture of Membranes: An Observational Study. Cureus. 2022; 14(5):e25533. [PMID: 35844210]
Bohîlțea RE, et al. Expectant Management of PPROM Improves Neonatal Outcome—A Retrospective Study of 562 Patients. J Clin Med. 2022;11(1):214. [PMID: 35011954]
Yoon BH, Romero R, Park JS, et al. Serum C-reactive protein, white blood cell count, and neutrophil count in preterm labor: a comparison between the amniotic fluid-infected and non-infected groups. Am J Obstet Gynecol. 1996;174(5):1421–1427. [PMID: 8623865]
Gomez R, Romero R, Ghezzi F, et al. The fetal inflammatory response syndrome. Am J Obstet Gynecol. 1998 Jul;179(1):194–202. [PMID: 9704787]
Mahajan N, Aggarwal M. Maternal and neonatal complications in preterm premature rupture of membranes. Int J Reprod Contracept Obstet Gynecol. 2017;6(9):3915–3920. [PubMed Indexed]Patil S, Patil V. Maternal and fetal outcome in premature rupture of membranes. IOSR J Dent Med Sci. 2014;13:56–83. [PubMed PMID: 25653964]
Downloads
Published
How to Cite
Issue
Section
License

This work is licensed under a Creative Commons Attribution 4.0 International License.
You are free to:
- Share — copy and redistribute the material in any medium or format
- Adapt — remix, transform, and build upon the material for any purpose, even commercially.
Terms:
- Attribution — You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
- No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.